Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00511329 · ClinicalTrials.gov registry record · Phase 2
Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease
A Phase 2 study, sponsored by Nationwide Children's Hospital.
- Terminated
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT00511329 is a Phase 2 study that was terminated before completion, run by Nationwide Children's Hospital. The registered enrollment target is 10 participants.
The verdict
NCT00511329, a Phase 2 study, was terminated before completion, sponsored by Nationwide Children's Hospital.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The investigators hypothesize that the anabolic effects of Genotropin (somatropin) will improve the height and weight of children with inflammatory based chronic illness who have failed to grow despite receiving adequate nutrition. The investigators will test the hypothesis by treating 32 chronically ill children (16 JRA and 16 Crohn's) with growth hormone (GH) for 12 months and comparing them to baseline.
Interventions
- DRUG somatropin [rDNA origin] for injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00511329
The ClinicalTrials.gov registry entry for NCT00511329 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which somatropin [rDNA origin] for injection is the first listed.
NCT00511329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00511329 about?
NCT00511329 is a clinical study titled "Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease". The investigators hypothesize that the anabolic effects of Genotropin (somatropin) will improve the height and weight of children with inflammatory based chronic illness who have failed to grow despite receiving adequate nutrition. The investigators will test the hypothesis by treating 32 chronicall...
What is the current status of trial NCT00511329?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2007-08. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00511329?
The interventions under investigation include: somatropin [rDNA origin] for injection (DRUG).
Who is sponsoring clinical trial NCT00511329?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.